# S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

> **NCT00003824** · PHASE3 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 114 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** cephalexin
- **PROCEDURE:** surgical procedure
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT00003824
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-04
- **Primary completion:** 2001-07
- **Final completion:** 2007-01
- **Target enrollment:** 114 (ACTUAL)
- **Why stopped:** Permanently Closed Due to Poor Accrual
- **Last updated:** 2012-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003824, "S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*